Verorab Szczepionka

Verorab Szczepionka: A Comprehensive Guide to the COVID-19 Vaccine

Introduction

Verorab Szczepionka, also known as the COVAXIN vaccine, is an inactivated SARS-CoV-2 vaccine developed by Bharat Biotech. It has been approved for use in several countries, including India, Iran, and Zimbabwe. COVAXIN is a whole-virion vaccine, meaning it contains the entire virus, which has been inactivated so that it cannot cause disease. COVAXIN has been shown to be effective against COVID-19 in clinical trials. In a phase 3 trial, the vaccine was found to be 81% effective in preventing symptomatic COVID-19 and 100% effective in preventing severe disease and hospitalization.

How does COVAXIN work?

COVAXIN works by stimulating the body's immune system to produce antibodies against SARS-CoV-2. These antibodies can then bind to the virus and prevent it from infecting cells.

Who should get COVAXIN?

COVAXIN is recommended for people aged 18 and older. It is especially important for people who are at high risk of developing severe COVID-19, such as people with underlying medical conditions.

What are the side effects of COVAXIN?

The most common side effects of COVAXIN are pain at the injection site, fever, fatigue, headache, and muscle pain. These side effects are usually mild and resolve within a few days.

How is COVAXIN administered?

COVAXIN is administered as a two-dose intramuscular injection. The second dose should be given 4-6 weeks after the first dose.

How effective is COVAXIN?

COVAXIN has been shown to be effective against COVID-19 in clinical trials. In a phase 3 trial, the vaccine was found to be 81% effective in preventing symptomatic COVID-19 and 100% effective in preventing severe disease and hospitalization.

Is COVAXIN safe?

COVAXIN has been shown to be safe in clinical trials. The most common side effects are mild and resolve within a few days.

Conclusion

COVAXIN is a safe and effective vaccine against COVID-19. It is recommended for people aged 18 and older, especially those who are at high risk of developing severe disease.